Home Medicine Three new Brazilian cases of 17α-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features
Article
Licensed
Unlicensed Requires Authentication

Three new Brazilian cases of 17α-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features

  • Ikaro Soares Santos Breder EMAIL logo , Heraldo Mendes Garmes , Tais Nitsch Mazzola , Andrea Trevas Maciel-Guerra , Maricilda Palandi de Mello and Gil Guerra-Júnior
Published/Copyright: July 9, 2018

Abstract

Background:

Deficiency of 17α-hydroxylase (17OHD) is a rare form of adrenal hyperplasia. Diagnosis is generally delayed, impairing appropriate treatment.

Case presentation:

Here, we report the clinical, molecular, hormonal, and treatment data of three unrelated 17OHD patients, aged 14–16 years with hypergonadotrophic hypogonadism; uncontrolled hypertension; primary adrenal insufficiency; and high progesterone, low to normal potassium, and low dehydroepiandrosterone, androstenedione, and testosterone levels. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) at baseline and after an adrenocorticotropic hormone test showed low cortisol and cortisone and high deoxycorticosterone (DOC) and corticosterone levels; both DOC/21-deoxycortisol and costicosterone/cortisol ratios were very high. Patient 2 had 46,XX karyotype and patients 1 and 3, had 46,XY. A molecular analysis showed that two of the patients were homozygous for p.W406R mutation and the other patient was compound heterozygous for p.W406R and p.P428L. Hypertension was controlled only after the administration of both prednisone and mineralocorticoid antagonist.

Conclusions:

Hypertension in young women must lead to diagnostic suspicion, even in the pre-pubertal period. The basal level of progesterone is an indicator of 17OHD. Mineral and glucocorticoid ratios obtained from LC-MS/MS can reinforce the diagnosis. Hypertension can be controlled using glucocorticoid replacement therapy and mineralocorticoid antagonist.

Acknowledgments

We thank the Fleury Medicine and Health Laboratory in São Paulo, Brazil, for the hormonal profile analysis by LC-MS/MS.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This research was supported by a grant from the National Council for Scientific and Technological Development, Funder Id: 10.13039/501100003593 (CNPq – Process number 302870/2013-0 obtained by GG-J).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 2001;30:101–9, vii.10.1016/S0889-8529(08)70021-5Search in Google Scholar

2. Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol 2017;165:71–8.10.1016/j.jsbmb.2016.02.002Search in Google Scholar PubMed PubMed Central

3. Chung BC, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 1987;84:407–11.10.1073/pnas.84.2.407Search in Google Scholar PubMed PubMed Central

4. Picado-Leonard J, Miller WL. Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 1987;6:439–48.10.1089/dna.1987.6.439Search in Google Scholar PubMed

5. Costa-Santos M, Kater CE, Auchus RJ, Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 2004;89:49–60.10.1210/jc.2003-031021Search in Google Scholar PubMed

6. Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, et al. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 2003;88:5739–46.10.1210/jc.2003-030988Search in Google Scholar PubMed

7. Fontenele R, Costa-Santos M, Kater CE. 17α-hydroxylase deficiency is an underdiagnosed disease. High frequency of misdiagnoses in a large cohort of Brazilian patients. Endocr Pract 2017;24:170–8.10.4158/EP171987.ORSearch in Google Scholar PubMed

8. Liu BL, Qiao J, Chen X, Liang J, Zuo CL, et al. Clinical and molecular genetic analysis for 7 patients from 5 pedigrees with 17α-hydroxylase/17,20 lyase deficiency. Chinese J Med Genet 2009;26:282–7.Search in Google Scholar

9. Tao H, Lu ZL, Zhang B, Mi SH, Wang NY, et al. Study on the genetic mutations of 17 alpha-hydroxylase/17,20-lyase deficiency in Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006;23:125–8.Search in Google Scholar

10. Wei JQ, Wei JL, Li WC, Bi YS, Wei FC. Genotyping of five Chinese patients with 17alpha-hydroxylase deficiency diagnosed through high-performance liquid chromatography serum adrenal profile: identification of two novel CYP17 mutations. J Clin Endocrinol Metab 2006;91:3647–53.10.1210/jc.2006-0153Search in Google Scholar PubMed

11. Yang J, Cui B, Sun S, Shi T, Zheng S, et al. Phenotype-genotype correlation in eight Chinese 17α-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 2006;91:3619–25.10.1210/jc.2005-2283Search in Google Scholar PubMed

12. Tian Q, Yao F, Sha G, Huang S, Tseng H, Schindler AE. Genotyping of a Chinese family with 46,XX and 46,XY 17-hydroxylase deficiency. Gynecol Endocrinol 2009;25: 485–90.10.1080/09513590902898239Search in Google Scholar PubMed

13. Han B, Xue L, Fan M, Zhao S, Liu W, Zhu H, et al. Clinical and molecular manifestation of fifteen 17OHD patients: a novel mutation and a founder effect. Endocrine 2016; 53:784–90.10.1007/s12020-016-0957-ySearch in Google Scholar

14. Fardella CE, Zhang LH, Mahachoklertwattana P, Lin D, Miller WL. Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 1993;77:489–93.10.1210/jcem.77.2.8345056Search in Google Scholar

15. Kater CE, Biglieri EG. Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol Metab Clin North Am 1994;23:341–57.10.1016/S0889-8529(18)30101-4Search in Google Scholar

16. De Paula GB, Barros BA, Carpini S, Tincani BJ, Mazzola TN, et al. 408 cases of genital ambiguity followed by single multidisciplinary team during 23 years: etiologic diagnosis and sex of rearing. Int J Endocrinol 2016;2016:4963574.10.1155/2016/4963574Search in Google Scholar PubMed PubMed Central

17. Belgini DR, Mello MP, Baptista MT, Oliveira DM, Denardi FC, et al. Six new cases confirm the clinical molecular profile of complete combined 17α-hydroxylase/17,20-lyase deficiency in Brazil. Arq Bras Endocrinol Metab 2010;54:711–6.10.1590/S0004-27302010000800008Search in Google Scholar

18. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press 2014;23:3–16.10.3109/08037051.2014.868629Search in Google Scholar PubMed

19. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–89.10.1210/jc.2015-1710Search in Google Scholar PubMed PubMed Central

20. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889–916.10.1210/jc.2015-4061Search in Google Scholar PubMed

Received: 2017-12-10
Accepted: 2018-06-11
Published Online: 2018-07-09
Published in Print: 2018-08-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Urinary bisphenol-A levels in children with type 1 diabetes mellitus
  4. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome
  5. Association of anthropometric measures and cardio-metabolic risk factors in normal-weight children and adolescents: the CASPIAN-V study
  6. The effect of obesity and insulin resistance on macular choroidal thickness in a pediatric population as assessed by enhanced depth imaging optical coherence tomography
  7. Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): clinical heterogeneity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation
  8. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning
  9. Screening for autoimmune thyroiditis and celiac disease in minority children with type 1 diabetes
  10. Resistance exercise alone improves muscle strength in growth hormone deficient males in the transition phase
  11. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)
  12. Symptomatic Rathke cleft cyst in paediatric patients – clinical presentations, surgical treatment and postoperative outcomes – an analysis of 38 cases
  13. Molecular genetics of tetrahydrobiopterin deficiency in Chinese patients
  14. Single center experience of biotinidase deficiency: 259 patients and six novel mutations
  15. Next-generation sequencing as a second-tier diagnostic test for newborn screening
  16. Case Reports
  17. Thyroid storm after choking
  18. Three new Brazilian cases of 17α-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features
  19. Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis
  20. Refractory hypoglycemia in a pediatric patient with desmoplastic small round cell tumor
Downloaded on 24.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0521/pdf
Scroll to top button